Literature DB >> 27542011

Nanotechnology Treatment Options for Osteoporosis and Its Corresponding Consequences.

Donglei Wei1,2, Jinsuh Jung2,3, Huilin Yang1,2, David A Stout4,5, Lei Yang6,7.   

Abstract

Unfortunately, osteoporosis, as a worldwide disease, is challenging human health with treatment only available for the symptoms of osteoporosis without managing the disease itself. Osteoporosis can be linked as the common cause of fractures and increased mortality among post-menopausal women, men, and the elderly. Regrettably, due to osteoporosis, incidents of fractures are more frequent among the presented populations and can be afflictive for carrying out everyday life activities. Current treatments of osteoporosis encompass changing lifestyles, taking orthopedic drugs, and invasive surgeries. However, these treatment options are not long lasting and can lead to complications after post-surgical life. Therefore, to solve this impairment, researchers have turned to nanotechnologies and nanomaterials to create innovative and alternative treatments associated with the consequences of osteoporosis. This review article provides an introduction to osteoporotic compression vertebral fractures (OVCFs) and current clinical treatments, along with the rationale and efficacy of utilizing nanomaterials to modify and improve biomaterials or instruments. The methods of applying bioactive agents (bone morphogenetic protein-2 (BMP-2), parathyroid hormone 1-34 (PTH 1-34)), as well as 3D printing will be presented from an osteoporosis treatment perspective. Additionally, the application of nanoparticles and nanotube arrays onto the current surgical treatments and orthopedic drug administration methods addressed will show that these systems reinforce a better mechanical performance and provide precise and slow-releasing drug delivery for better osseointegration, bone regeneration, and bone strength. In summary, nanomaterials can be seen as an alternative and more effective treatment for individuals with osteoporosis.

Entities:  

Keywords:  3D printing; Bioactive agents; Injectable materials; Nanotechnology; Osteoporosis; Osteoporotic vertebral compression fracture

Mesh:

Substances:

Year:  2016        PMID: 27542011     DOI: 10.1007/s11914-016-0324-1

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  72 in total

1.  Nantotechniques and approaches in biotechnology.

Authors:  A Curtis; C Wilkinson
Journal:  Trends Biotechnol       Date:  2001-03       Impact factor: 19.536

Review 2.  Bone tissue engineering: state of the art and future trends.

Authors:  António J Salgado; Olga P Coutinho; Rui L Reis
Journal:  Macromol Biosci       Date:  2004-08-09       Impact factor: 4.979

3.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

4.  Biomechanical evaluation of kyphoplasty with calcium sulfate cement in a cadaveric osteoporotic vertebral compression fracture model.

Authors:  Andrew Perry; Andrew Mahar; Jennifer Massie; Noemi Arrieta; Steven Garfin; Choll Kim
Journal:  Spine J       Date:  2005 Sep-Oct       Impact factor: 4.166

5.  Bone health: osteoporosis, calcium and vitamin D.

Authors:  Didier Garriguet
Journal:  Health Rep       Date:  2011-09       Impact factor: 4.796

6.  The treatment of symptomatic osteoporotic spinal compression fractures.

Authors:  Stephen I Esses; Robert McGuire; John Jenkins; Joel Finkelstein; Eric Woodard; William C Watters; Michael J Goldberg; Michael Keith; Charles M Turkelson; Janet L Wies; Patrick Sluka; Kevin M Boyer; Kristin Hitchcock
Journal:  J Am Acad Orthop Surg       Date:  2011-03       Impact factor: 3.020

7.  Prolonged presence of VEGF promotes vascularization in 3D bioprinted scaffolds with defined architecture.

Authors:  Michelle T Poldervaart; Hendrik Gremmels; Kelly van Deventer; Joost O Fledderus; F Cumhur Oner; Marianne C Verhaar; Wouter J A Dhert; Jacqueline Alblas
Journal:  J Control Release       Date:  2014-04-13       Impact factor: 9.776

Review 8.  Nanotechnology for treating osteoporotic vertebral fractures.

Authors:  Chunxia Gao; Donglei Wei; Huilin Yang; Tao Chen; Lei Yang
Journal:  Int J Nanomedicine       Date:  2015-08-13

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

Review 10.  Designs and techniques that improve the pullout strength of pedicle screws in osteoporotic vertebrae: current status.

Authors:  Thomas M Shea; Jake Laun; Sabrina A Gonzalez-Blohm; James J Doulgeris; William E Lee; Kamran Aghayev; Frank D Vrionis
Journal:  Biomed Res Int       Date:  2014-03-03       Impact factor: 3.411

View more
  3 in total

1.  Development of zoledronic acid functionalized hydroxyapatite loaded polymeric nanoparticles for the treatment of osteoporosis.

Authors:  Yunlu Cai; Tiantian Gao; Shiping Fu; Ping Sun
Journal:  Exp Ther Med       Date:  2018-06-07       Impact factor: 2.447

Review 2.  Nanotechnology-based drug delivery systems in orthopedics.

Authors:  Eylem Güven
Journal:  Jt Dis Relat Surg       Date:  2021-01-06

3.  Fabrication of multifunctional alginate microspheres containing hydroxyapatite powder for simultaneous cell and drug delivery.

Authors:  Jueun Kim; Yeong-Jin Choi; Honghyun Park; Hui-Suk Yun
Journal:  Front Bioeng Biotechnol       Date:  2022-08-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.